June 25, 2022

India approves Roche antibody cocktail for Covid treatment



Roche India informed that it Central Drugs Standards Control Organisation (CDSCO) has provided an Emergency Use Authorisation for Roche’s antibody cocktail that is indicated for the treatment of mild to moderate COVID-19. This approval was based on the data that have been filed for the EUA in the U.S and the scientific opinion of the Committee for Medicinal Products for Human. Watch video.

View at DailyMotion

Connect us

Our social contacts